Lumed

Lumed is a cutting-edge software company dedicated to optimizing clinical practices in infectious diseases, improving antimicrobial governance, and enhancing patient care quality. The company serves healthcare institutions, including hospitals and clinics, primarily in Europe, Canada, and the US. Lumed operates in the healthcare technology market, focusing on providing advanced software tools that facilitate efficient data access and management in clinical settings. Its core products include the Antimicrobial Prescription Surveillance System (APSS) and ZINC software. APSS helps antimicrobial stewardship teams improve the efficiency of revising prescriptions and alerting pharmacists for optimal patient follow-up. ZINC software aids infection prevention teams in controlling and preventing nosocomial infections in real-time. Lumed generates revenue through the sale and distribution of its software solutions, supported by strategic equity investments and partnerships with entities like ACET Capital, Bank of Development of Canada for Quebec Regions, Desjardins, Economic Development Canada, and Can Export.

Keywords: antimicrobial governance, clinical practice optimization, healthcare technology, infection prevention, APSS software, ZINC software, patient care, hospital data management, nosocomial infections, strategic investments.